Journal article
Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model
Journal of neuroimmunology, v 305, pp 162-166
15 Apr 2017
PMID: 28284338
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Recent studies suggest a need for refinement of the traditional two phase model of relapse onset multiple sclerosis (RMS) to include dynamically changing subgroups within the broad category of secondary progressive MS (SPMS). These studies challenge the traditional notion that relapses play a minor role in comparison to a secondary progressive (perhaps degenerative) process. Patients fulfilling the broad definition for SPMS may take several courses, including variable rates and patterns of overall worsening. New paradigms or models for mapping the trajectory of disability in RMS and SPMS (clinical phenotyping), including periods of remission, may impact our understanding of the underlying pathology, and will be important in assessing treatments.
•Relapse with immediate sequella is common in relapse onset multiple sclerosis (RMS).•Severe worsening in RMS often occurs stepwise rather than slowly.•Stepwise worsening at any time is predictive of long term worsening.•These findings represent a refinement of the 2 stage model of RMS.
Metrics
Details
- Title
- Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model
- Creators
- Thomas F. Scott - Allegheny General Hospital
- Publication Details
- Journal of neuroimmunology, v 305, pp 162-166
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Neurology
- Web of Science ID
- WOS:000397694200026
- Scopus ID
- 2-s2.0-85013040925
- Other Identifier
- 991019167575904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Immunology
- Neurosciences